OTC Markets OTCQB - Delayed Quote USD

InnoCan Pharma Corporation (INNPF)

0.1400
0.0000
(0.00%)
At close: May 13 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
29,437
29,437
--
2,559
196
Cost of Revenue
3,250
3,250
--
452
75
Gross Profit
26,187
26,187
--
2,107
121
Operating Expense
27,434
27,434
--
8,373
7,601
Operating Income
-1,247
-1,247
--
-6,266
-7,480
Net Non Operating Interest Income Expense
-7
-7
--
19
-13
Other Income Expense
2,173
2,173
--
2,359
-2,598
Pretax Income
919
919
--
-3,888
-10,091
Tax Provision
1,181
1,181
--
1
0
Net Income Common Stockholders
-1,834
-1,834
--
-3,764
-10,047
Diluted NI Available to Com Stockholders
-1,834
-1,834
--
-3,764
-10,047
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Basic Average Shares
275,053.5990
280,040.8420
257,003.7750
248,953.2200
224,541.7800
Diluted Average Shares
275,053.5990
280,040.8420
257,003.7750
248,953.2200
224,541.7800
Total Operating Income as Reported
-1,247
-1,247
--
-6,266
-7,480
Rent Expense Supplemental
--
--
--
198
84
Total Expenses
30,684
30,684
--
8,825
7,676
Net Income from Continuing & Discontinued Operation
-1,834
-1,834
--
-3,764
-10,047
Normalized Income
-3,681.0500
-3,681.0500
--
-5,504.7061
-7,449
Interest Income
0
0
--
21
--
Interest Expense
7
7
--
2
13
Net Interest Income
-7
-7
--
19
-13
EBIT
926
926
--
-3,886
-10,078
EBITDA
961
961
--
-3,851
-10,035
Reconciled Cost of Revenue
3,250
3,250
--
452
75
Reconciled Depreciation
35
35
--
35
43
Net Income from Continuing Operation Net Minority Interest
-1,834
-1,834
--
-3,764
-10,047
Total Unusual Items Excluding Goodwill
2,173
2,173
--
2,359
-2,598
Total Unusual Items
2,173
2,173
--
2,359
-2,598
Normalized EBITDA
-1,212
-1,212
--
-6,210
-7,437
Tax Rate for Calcs
0.0002
0.0002
--
0.0003
0
Tax Effect of Unusual Items
325.9500
325.9500
--
618.2939
0
12/31/2021 - 11/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NMV.F Captor Capital Corp.
0.2200
+3.77%
 
MILFF 1CM Inc.
0.1942
0.00%
 
LVRLF CordovaCann Corp.
0.0700
0.00%
 
LIFD LFTD Partners Inc.
0.3700
0.00%
 
BSPK Bespoke Extracts, Inc.
0.1023
0.00%
 
HYEX Healthy Extracts Inc.
2.9900
+6.79%
 
AYURF Ayurcann Holdings Corp.
0.0176
0.00%
 
XBRAF Xebra Brands Ltd.
0.0340
+6.58%
 
LOVFF Cannara Biotech Inc.
0.9345
0.00%
 
DBCCF Decibel Cannabis Company Inc.
0.0474
-5.20%